Cleveland House

Cleveland House is an addiction-treatment facility located in Toms River, NJ. The facility's programming is outpatient (Outpatient, MAT), not residential. What follows is an orientation — not a review — to the practical questions worth asking before admission.

Care levels at Cleveland House

The care-level question matters because what a facility offers is what it can realistically treat well. Cleveland House is an outpatient-focused program (Outpatient, MAT) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. Before admission, an independent clinical assessment (from a primary-care doctor, licensed substance-use counselor, or addiction-medicine physician) can confirm whether Cleveland House's offerings match the clinical need.

Insurance and payment

Cleveland House accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. The single most useful pre-admission move on insurance is requesting the facility send you — in writing, by email — the specific benefits verification for your specific plan product. That document is the answer to most post-admission billing disputes.

Specialty programming

The facility's documented specialty programming includes: Young adults, Adult women, Pregnant/postpartum women. If that matches what you or your family member need, great — and worth asking specifically about what the programming looks like day-to-day (how many hours per week of specialty-specific content, who leads it, what credentials they hold).

Before you call

The three questions that consistently separate programs worth considering from programs worth skipping: ASAM level of care match; written VOB for your plan; MAT policy. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation. Programs that cannot answer all three quickly are programs worth approaching with caution.